Alaunos Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 1.95 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 4.95M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.